Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Autor: Bang, Yung-Jue, Van Cutsem, Eric, Feyereislova, Andrea, Chung, Hyun C, Shen, Lin, Sawaki, Akira, Lordick, Florian, Ohtsu, Atsushi, Omuro, Yasushi, Satoh, Taroh, Aprile, Giuseppe, Kulikov, Evgeny, Hill, Julie, Lehle, Michaela, Rüschoff, Josef, Kang, Yoon-Koo
Zdroj: In The Lancet 2010 376(9742):687-697
Databáze: ScienceDirect